{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:31:39Z","timestamp":1740130299493,"version":"3.37.3"},"reference-count":4,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,1]]},"DOI":"10.1093\/qjmed\/hcx022","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T08:25:02Z","timestamp":1485764702000},"page":"263-264","source":"Crossref","is-referenced-by-count":0,"title":["Response to letter regarding article, \u2018proton pump inhibitors in IPF: beyond mere suppression of gastric acidity\u2019"],"prefix":"10.1093","volume":"110","author":[{"given":"Y.T.","family":"Ghebre","sequence":"first","affiliation":[{"name":"From the Department of Radiation Oncology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Raghu","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Center for Interstitial Lung Disease (ILD), University of Washington, Seattle, Washington DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"key\n\t\t\t\t20180314123404_hcx022-B1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/qjmed\/hcw115","article-title":"Proton pump inhibitors in IPF: beyond mere suppression of gastric acidity","volume":"109","author":"Ghebre","year":"2016","journal-title":"Qjm"},{"key":"key\n\t\t\t\t20180314123404_hcx022-B2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t20180314123404_hcx022-B3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.113.003602","article-title":"Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine","volume":"128","author":"Ghebremariam","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180314123404_hcx022-B4","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00424.2007","article-title":"Nitric oxide deficiency in chronic kidney disease","volume":"294","author":"Baylis","year":"2008","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/110\/4\/263\/24352619\/hcx022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T12:35:45Z","timestamp":1521030945000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/110\/4\/263\/2966142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":4,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,2,2]]},"published-print":{"date-parts":[[2017,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcx022","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"type":"print","value":"1460-2725"},{"type":"electronic","value":"1460-2393"}],"subject":[],"published-other":{"date-parts":[[2017,4]]},"published":{"date-parts":[[2017,2,2]]}}}